Ir-catalyzed sp(3) C-H alkylation of γ-butyrolactam with alkenes was used for the highly enantioselective synthesis of 5-substituted γ-lactams, which were readily converted into chiral 4-substituted γ-amino acids. A broad scope of alkenes was amenable as coupling partners, and the alkylated product using acrylate could be transformed into the key intermediate of pyrrolam A synthesis.
4-Substituted tryptophan derivatives and the total synthesis of cis-clavicipitic acid were achieved in reactions in which Ir-catalyzed C-H bond activation was a key step. The starting material for these reactions is asparagine, which is a cheap natural amino acid. The reductive amination step from the 4-substituted tryptophan derivative gave cis-clavicipitic acid with perfect diastereoselectivity.
A new π‐conjugated system of nitrogen‐containing polycyclic compounds was constructed by cationic AuI‐catalyzed cycloisomerization. Intramolecular reaction of 9‐(2‐alkynylphenyl)‐9H‐carbazole derivatives gave a variety of penta‐ and hexacyclic compounds possessing a dibenzazepine skeleton. The rigid carbazole structure was responsible for efficient 7‐endo‐dig cycloisomerization.
Enantioselective
synthesis of azepine-fused planar-chiral ferrocenes
was achieved by the chiral cationic Pt-catalyzed intramolecular cycloisomerization
of N-propargyl-2-ferrocenylanilines. A mechanistic
study using an N-allenyl analogue indicated that
the reaction proceeded selectively in a 7-exo-dig manner along with isomerization of the exo-olefin moiety. A methanesulfonylamino tether was crucial for selective
cycloisomerization. This is the first example of the enantioselective
synthesis of heteropin-fused planar-chiral ferrocenes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.